Real-world application of CGM technology to improve diabetes management in primary care

Ask a question

Welcome to our expert-led, independent medical education program that aims to refine clinicians’ competency and skills integrating CGM technology into their clinical practice.

This program provides US-based primary care physicians (PCPs) with relevant context for applying CGM knowledge, experiential learning of patient management using CGM devices, and practicing of clinical decision-making skills based on CGM device readouts and data.

We also highlight key information for implementing a shared decision-making approach and for optimal communication between the clinician and patient.

Explore how best to utilize CGM to enhance diabetes management and optimize patient outcomes!

Read more

For CME-accredited activities, look for the badge

Interested in learning more? Dr. Joseph Henske discusses the activities and goals of this CME Program.

Meet the faculty

Program Director

Joseph A Henske, MD

UAMS Health, Little Rock, AR

Dr. Henske is an associate professor of medicine and the director of the diabetes program at UAMS Health. Before joining UAMS in 2019, he worked in full-time clinical practice and served as the department chair of endocrinology for DuPage Medical Group in Chicago, IL.  He currently maintains a busy clinical practice, works on several NIH-funded research projects, speaks at local, regional, and national meetings, and is involved in the teaching and training of resident physicians and endocrinology fellows at UAMS, both in the inpatient and outpatient settings.

Dr. Henske’s current clinical and research interests include type 1 diabetes, type 2 diabetes, diabetes management surrounding exercise, and closed-loop automated insulin delivery systems.

Diagnosed with type 1 diabetes himself at the age of 15, Dr. Henske has committed his life to helping others with diabetes better manage their disease and live life to the fullest. He has been a longtime supporter of Breakthrough T1D (formerly the Juvenile Diabetes Research Foundation) and is an advocate for increasing diabetes awareness, helping improve access to medications and technologies for patients, and has been involved in research to one day find better ways to prevent, treat, and cure this disease. He has had a lifelong passion for running including having completed 14 marathons and encourages his patients to include exercise as a key component in the treatment of their diabetes. Outside the clinic he enjoys spending time with family, especially his wife Lauren and their seven children.

Disclosures:

  • Dr. Henske has no financial relationships to disclose.

Vivian Fonseca, MD, FRCP

Tulane University School of Medicine, New Orleans, LA

Dr. Fonseca is Professor of Medicine, Assistant Dean for Clinical Research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the Section of Endocrinology at Tulane University Medical Center in New Orleans, Louisiana. He is a Past President for Science and Medicine of the American Diabetes Association (2012) and has served on the ADA Board of Directors and several committees. He has served on the Board of Directors of the American Association of Clinical Endocrinologists (AACE), and the Board of Trustees of the American College of Endocrinology. He has served on committees writing guidelines for both organizations. He has held a leadership role and served on various committees in several other organizations including the American Board of Internal Medicine. He has received several awards including Banting Medal for Leadership and Service from The American Diabetes Association, the Seale – Harris award from the Southern Medical Association, and the Gerald Reaven award from the World Congress in Insulin Resistance. He has received several teaching awards and was elected to the Alpha Omega Alpha Honor Medical Society and has been listed for several years among the Best Doctors in the USA and for several years rated by Expertscape among the top 10 experts in Diabetes worldwide. Dr. Fonseca is a fellow of the Royal College of Physicians (London).

He plays a significant role in Clinical Research as Assistant Dean at Tulane University, and in its partnership with the Louisiana Clinical and Translational Science (LACaTS) Program. Dr Fonseca has served as Associate Director of the Aging and Cardiometabolic COBREs and a mentor and committee member in BIRCWH. He a strong interest in facilitating clinical research and developing the next generation of translational researchers. He is the Medical Director of the Tulane Clinical Trials Unit and Director of the Research Professional Development Core, which runs the Masters in Science in Clinical Research degree course.

Dr. Fonseca’s research interests include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease, particularly on the role of inflammation and other novel risk factors. He has a research program evaluating inflammation in diabetes and using technology to improve diabetes care in underprivileged populations, especially the development and use of a novel diabetes risk engine (BRAVO) in clinical practice. He is Co – PI of REACHNET a large network that conducts research utilizing electronic health records of over 2 million people across several states. He is the site PI of several large national research programs including 1. the All of Us Program, 2. COVID related studies – N3C utilizing EMR data about COVID and the RECOVER study which will evaluate long term COVID complications in a large cohort.

Disclosures:

  • Employee/Owner: Eli Lilly, Corcept
  • Consultant/Advisory Board: Asahi, Bayer, Abbott, Boehringer Ingelheim, Corcept
  • Grants (paid to institution): Fractyl, Jaguar Gene Therapy
  • Stockholder: Amgen, Abbott
  • Stock Options: Mellitus Health, BRAVO4Health
  • Patents Pending: BRAVO risk engine for predicting diabetes complications; PAX4 gene therapy for type 1 diabetes

Anne Peters, MD

Keck School of Medicine, USC, Los Angeles, CA

Dr. Peters is a professor at the Keck School of Medicine of the University of Southern California. She runs diabetes centers in Beverly Hills and in underserved East Los Angeles. She has been a PI on multiple grants, has authored over 250 articles and 4 books and has given lectures around the world. Her major interests involve translating research findings, from lifestyle interventions to technology, to people with diabetes throughout the socioeconomic spectrum. She has been part of the ADA/EASD writing group on the management of type 2 diabetes, the co-chair for the EASD/ADA writing group for the treatment of type 1 diabetes, a member of the Professional Practice Committee writing the ADA Standards of Care and the Chair of the Endocrine Society Technology Guideline Writing Group. She was awarded the ADA Outstanding Physician Clinician Award, the Bernardo Alberto Houssay Award from the National Minority Quality Forum and the Laureate Award for Public Service from the Endocrine Society.

Disclosures:

  • Grants: Abbott Diabetes Care, Dexcom, Insulet
  • Consultant/Advisory Board: Abbott Diabetes Care, Medscape, Vertex, Zealand
  • Stock Ownership/Stock options: Omada Health, Teladoc (past)

About the program

This comprehensive educational program includes CME-accredited interactive case studies which focuses on clinical reasoning and decision-making skills, and patient communication and education. In addition, the CME-accredited patient-provider interview showcases optimal shared decision-making techniques guiding patient care with CGM devices.

Learning objectives

Following completion of this independent educational program, you will be able to:

Target audience

Our program is aimed at US-based primary care physicians who are looking to improve their knowledge and skills in CGM technology for patients with T2D.

Accreditation

In support of improving patient care, this activity has been planned and implemented by Postgraduate Institute for Medicine and Springer Healthcare IME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures

In addition to the expert faculty, Postgraduate Institute for Medicine and Springer Healthcare IME planners and staff include Holly Keatts, Judith Mitchek, Maria Glukhovsky, Elizabeth Samander, Alessandra Geffner-Smith, and Jennifer Jett. The Planning Committee have no financial relationships to disclose.

All relevant financial relationships of the Faculty have been mitigated.

CME-accredited activities

Case Studies

Put your clinical decision-making skills to the test in our interactive case studies which examines crucial factors for incorporating CGMs into a patient-centric approach to manage diabetes.

(0.75 AMA PRA Category 1 Credits™)

Patient Interview

Join the conversation between our diabetes expert and an actual patient, as they provide guidance on how to improve communication between the clinician and patient.

(0.25 AMA PRA Category 1 Credits™)

* Video content will be summarized into a downloadable PDF for use in clinical practice.